National Research Centre

Medical Research Ethics Committee

MREC Reviewer Comment

Protocol Title

Development of Alginate-Lignin Composite Materials for Wound Healing Applications in rat model

Completely satisfied and informative data

Needs Explanation

Comments to the applicant

 PROTOCOL REVIEW CHECKLIST

 

IRB # _________

Title of Research Protocol: Development of Alginate-Lignin Composite Materials for Wound Healing Applications in Rat Model


PI:   Mona Agwa

 

Research Path:
        Human Subjects Research

 

✓     Non Human Subjects Research

Research only involves the study of data from existing samples/documents that have been received either without identifiers or does not involve private information

 

        Exempt Research

        Research conducted in commonly accepted educational settings involving normal

            educational practices.

        Research Involves the study of existing samples that are either publicly available or has

identifiers and the investigator will record the data in such a manner that individuals cannot be identified.

        Research involves surveys, interviews, focus groups discussions UNLESS the

            information is obtained/recorded such that individuals can be identified AND the

 data will be damaging to the individual.

 

        Expedite Review

 

        Full Board Review

 

Purpose/Background/Justification

 
Briefly summarize study purpose, background, and justification.
 The main aim of the research work is to find natural alternatives to wound dressing membranes applied topically by using the potential of lignin/alginate biofilm in vivo on wounded male rats. The authors described in the background the importance of Lignin and its combination with alginate for wound healing applications.

 

Item for Revision
Yes
No
N/A
Comments
 
Are the investigators/study team well qualified?

 
 
The team of work specializes in microbiology, polymers, and clinical pathology
 
SOCIAL VALUE
 
 
 
 
 
·       Does the study address an important health issue of the community/country?

 
 
Production of natural alternatives, wound dressing membrane applied topically
 
·       Is the research gap significant enough to justify the conduct of this research?
 

 
There is much research work on the same topic
 
·       Does the community need to be involved in the design, implementation, or dissemination of the results of the study?

 
 
The production of natural wound dressings is essential for ensuring safe healing.
 
STUDY DESIGN
·       Are the objectives well described?

 
 
 
 
·       Is the scientific design able to address the objectives?

 
 
 
 
·       Is the statistical analysis well described?
 
 

 
 
·       Has a sample size been calculated?
 

 
The number of animals needs to be increased
 
SELECTION OF SUBJECTS
·       Is the recruitment of subjects described?
 
 

 
 
·       Does the recruitment process lead to a biased sample?
 
 

 
 
·       Does the setting of recruitment represent a coercive concern or an undue inducement?
 
 

 
 
·       Does the study involve vulnerable populations?
 
 

 
 
·       If yes, are additional safeguards included to protect the rights and welfare of the participants (e.g., limits on risk, parental consent)?
 
 

 
 
·       Are selection of participants justified?
 
 

 
 
RISK /BENEFIT ASSESSMENT
·       Are the foreseeable risks clearly defined? 
 
 

 
 
§  Physical risks?
 
 
 
 
 
§  Social risks?
 
 
 
 
 
§  Psychological risks?
 
 
 
 
 
§  Legal/political risks?
 
 
 
 
 
§  Economic risks?
 
 
 
 
 
·       Are risks minimized as much as possible (e.g., appropriate exclusion criteria, substitution of less risky interventions, etc)?
 
 

 
 
·       Are there potential direct benefits to individuals?

 
 
 
 
·       Is the benefit to society appropriate?

 
 
 
 
FINAL ASSESSMENT: Are risks to subjects reasonable when compared to anticipated direct benefits, if any, and to the knowledge to be gained?
 
 

 
 

 

DATA AND SAFETY MONITORING
Yes
No
N/A
Comments
 
·       Are there plans to monitor the data to ensure the safety of the participants?
 

 
The authors did not outline safety precautions for handling animals or how they will dispose of dead animals.
 
·       Is a Data and Safety Monitoring Board needed?
 

 
 
 
·       Other safety issues?
 

 
 
 
INFORMED CONSENT
·       Is the description of the informed consent process well described?
 
 

 
 
·       Does the consent form include the necessary elements of information?
 
 

 
 
·       If the research represent secondary analysis of data do the participants need to be re-contaced for consent?
 
 

 
 
·       Is surrogate consent needed?
 
 

 
 
·       Can informed consent be waived?
 
 

 
 
·       Can parental consent be waived?
 
 

 
 
·       Other informed consent concernss?
 
 

 
 
PRIVACY and CONFIDENTIALITY
·       Does the recruitment process respect privacy?
 
 

 
 
·       Are there provisions to protect privacy (e.g., interviews or focus groups conducted in a private area).
 
 

 
 
·       Are there adequate provisions to maintain the confidentiality of the data?
 
 

 
 
·       Other privacy and confidentiality concerns?
 
 

 
 
Conflict of Interest
 
·       Have the investigators/study team submitted COI forms?

 
 
 
 
Informed Consent Document
 
Statement that study involves research

 
 
 
 
Explanation of purposes and duration 
 

 
The 30-day timeframe is insufficient to complete animal experiments and histopathology.
 
Description of procedures

 
 
 
 
Identification of experimental procedures

 
 
 
 
Risks/discomforts 
Benefits 
 

 
 
 
Disclosure of alternatives
 
 

 
 
Confidentiality
 
 

 
 
Compensation and treatment for injury
 
 

 
 
Contact information

 
 
 
 
Voluntary participation / right to withdraw
 
 

 
 
Future use of data/specimens
 
 

 
 

 

Final Decision
Approval
 
Approval with clarifications
1. Specify the funding source for the experiments, especially since they have Spanish partners.

2. Increase the number of animals used to minimize losses during the experiments.

 3. Describe the proper disposal methods for dead animals after sample collection.

4-The Gantt chart was missing.
Approval with modifications
 
Defer until more information is obtained
 
Disapprove
 
CONTINUING REVIEW FREQUENCY

Regulations require continuing review must be at least every 12 months. The review period will reflect an interval appropriate to the degree of risk. More frequent review may be considered for research when the degree of risk warrants closer monitoring.
 
MAJOR CONCERNS ABOUT PROTOCOL
 
MINOR CONCERNS ABOUT PROTOCOL
 
GENERAL COMMENTS
 
 

            Prof. Dr. Omaima Kandil                                                    22-10-2025                

Signature of Primary Reviewer                              Date

 

 

 

 

Comment to the Committee

 PROTOCOL REVIEW CHECKLIST

 

IRB # _________

Title of Research Protocol: Development of Alginate-Lignin Composite Materials for Wound Healing Applications in Rat Model


PI:   Mona Agwa

 

Research Path:
        Human Subjects Research

 

✓     Non Human Subjects Research

Research only involves the study of data from existing samples/documents that have been received either without identifiers or does not involve private information

 

        Exempt Research

        Research conducted in commonly accepted educational settings involving normal

            educational practices.

        Research Involves the study of existing samples that are either publicly available or has

identifiers and the investigator will record the data in such a manner that individuals cannot be identified.

        Research involves surveys, interviews, focus groups discussions UNLESS the

            information is obtained/recorded such that individuals can be identified AND the

 data will be damaging to the individual.

 

        Expedite Review

 

        Full Board Review

 

Purpose/Background/Justification

 
Briefly summarize study purpose, background, and justification.
 The main aim of the research work is to find natural alternatives to wound dressing membranes applied topically by using the potential of lignin/alginate biofilm in vivo on wounded male rats. The authors described in the background the importance of Lignin and its combination with alginate for wound healing applications.

 

Item for Revision
Yes
No
N/A
Comments
 
Are the investigators/study team well qualified?

 
 
The team of work specializes in microbiology, polymers, and clinical pathology
 
SOCIAL VALUE
 
 
 
 
 
·       Does the study address an important health issue of the community/country?

 
 
Production of natural alternatives, wound dressing membrane applied topically
 
·       Is the research gap significant enough to justify the conduct of this research?
 

 
There is much research work on the same topic
 
·       Does the community need to be involved in the design, implementation, or dissemination of the results of the study?

 
 
The production of natural wound dressings is essential for ensuring safe healing.
 
STUDY DESIGN
·       Are the objectives well described?

 
 
 
 
·       Is the scientific design able to address the objectives?

 
 
 
 
·       Is the statistical analysis well described?
 
 

 
 
·       Has a sample size been calculated?
 

 
The number of animals needs to be increased
 
SELECTION OF SUBJECTS
·       Is the recruitment of subjects described?
 
 

 
 
·       Does the recruitment process lead to a biased sample?
 
 

 
 
·       Does the setting of recruitment represent a coercive concern or an undue inducement?
 
 

 
 
·       Does the study involve vulnerable populations?
 
 

 
 
·       If yes, are additional safeguards included to protect the rights and welfare of the participants (e.g., limits on risk, parental consent)?
 
 

 
 
·       Are selection of participants justified?
 
 

 
 
RISK /BENEFIT ASSESSMENT
·       Are the foreseeable risks clearly defined? 
 
 

 
 
§  Physical risks?
 
 
 
 
 
§  Social risks?
 
 
 
 
 
§  Psychological risks?
 
 
 
 
 
§  Legal/political risks?
 
 
 
 
 
§  Economic risks?
 
 
 
 
 
·       Are risks minimized as much as possible (e.g., appropriate exclusion criteria, substitution of less risky interventions, etc)?
 
 

 
 
·       Are there potential direct benefits to individuals?

 
 
 
 
·       Is the benefit to society appropriate?

 
 
 
 
FINAL ASSESSMENT: Are risks to subjects reasonable when compared to anticipated direct benefits, if any, and to the knowledge to be gained?
 
 

 
 

 

DATA AND SAFETY MONITORING
Yes
No
N/A
Comments
 
·       Are there plans to monitor the data to ensure the safety of the participants?
 

 
The authors did not outline safety precautions for handling animals or how they will dispose of dead animals.
 
·       Is a Data and Safety Monitoring Board needed?
 

 
 
 
·       Other safety issues?
 

 
 
 
INFORMED CONSENT
·       Is the description of the informed consent process well described?
 
 

 
 
·       Does the consent form include the necessary elements of information?
 
 

 
 
·       If the research represent secondary analysis of data do the participants need to be re-contaced for consent?
 
 

 
 
·       Is surrogate consent needed?
 
 

 
 
·       Can informed consent be waived?
 
 

 
 
·       Can parental consent be waived?
 
 

 
 
·       Other informed consent concernss?
 
 

 
 
PRIVACY and CONFIDENTIALITY
·       Does the recruitment process respect privacy?
 
 

 
 
·       Are there provisions to protect privacy (e.g., interviews or focus groups conducted in a private area).
 
 

 
 
·       Are there adequate provisions to maintain the confidentiality of the data?
 
 

 
 
·       Other privacy and confidentiality concerns?
 
 

 
 
Conflict of Interest
 
·       Have the investigators/study team submitted COI forms?

 
 
 
 
Informed Consent Document
 
Statement that study involves research

 
 
 
 
Explanation of purposes and duration 
 

 
The 30-day timeframe is insufficient to complete animal experiments and histopathology.
 
Description of procedures

 
 
 
 
Identification of experimental procedures

 
 
 
 
Risks/discomforts 
Benefits 
 

 
 
 
Disclosure of alternatives
 
 

 
 
Confidentiality
 
 

 
 
Compensation and treatment for injury
 
 

 
 
Contact information

 
 
 
 
Voluntary participation / right to withdraw
 
 

 
 
Future use of data/specimens
 
 

 
 

 

Final Decision
Approval
 
Approval with clarifications
1. Specify the funding source for the experiments, especially since they have Spanish partners.

2. Increase the number of animals used to minimize losses during the experiments.

 3. Describe the proper disposal methods for dead animals after sample collection.

4-The Gantt chart was missing.
Approval with modifications
 
Defer until more information is obtained
 
Disapprove
 
CONTINUING REVIEW FREQUENCY

Regulations require continuing review must be at least every 12 months. The review period will reflect an interval appropriate to the degree of risk. More frequent review may be considered for research when the degree of risk warrants closer monitoring.
 
MAJOR CONCERNS ABOUT PROTOCOL
 
MINOR CONCERNS ABOUT PROTOCOL
 
GENERAL COMMENTS
 
 

            Prof. Dr. Omaima Kandil                                                    22-10-2025                

Signature of Primary Reviewer                              Date

 

 

 

 

Informed consent form:

N/A

Login

Email Address *
Enter your username or email address
password *
Enter your password

Reset Password

Enter Your Email
Please insert your email and check your email for rest password link

Still not a member? Register